Physician profile
Maher A Khalaf
NPI 1679050983
$1,037.23
in general payments reported to CMS, 2019-2025
16 companies · $490 in 2025
The $490 reported for 2025 was more than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $130 · 2023: $174 · 2024: $244 · 2025: $490.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $908.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $907.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $246.23 | 2025 | Watchman Flx |
| Amgen INC. | $211.96 | 2023-2025 | Repatha |
| Edwards Lifesciences Corporation | $128.77 | 2024-2025 | Sapien 3 Ultra Resilia, Pascal |
| Ablative Solutions, INC. | $110.81 | 2021 | |
| Pfizer INC. | $69.79 | 2024-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $37.00 | 2023-2024 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $33.40 | 2025 | Farxiga |
| Novartis Pharmaceuticals Corporation | $32.19 | 2024-2025 | |
| Medtronic, INC. | $26.14 | 2024 | Corevalve Evolut R |
| Alnylam Pharmaceuticals INC. | $24.20 | 2024 | Onpattro |
| Novo Nordisk INC | $22.08 | 2025 | Ozempic |
| Sanofi-Aventis U.S. LLC | $21.29 | 2023 | |
| Lilly USA, LLC | $20.04 | 2025 | Zepbound |
| Biogen, INC. | $18.69 | 2021 | |
| United Therapeutics Corporation | $17.75 | 2024 | Tyvaso |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.89 | 2024 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maher Khalaf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.